Dynamic Technology Lab Private Ltd Has $324,000 Stock Holdings in Tenet Healthcare Corporation $THC

Key Points

• Dynamic Technology Lab Private Ltd reduced its holdings in Tenet Healthcare Corporation by 83.2% in the first quarter, decreasing its total shares to 2,410, worth approximately $324,000.
• CEO Saumya Sutaria sold 78,762 shares of Tenet for over $15 million, marking a significant 17.60% decrease in his ownership, while insider sales over the past 90 days totaled 90,722 shares valued at approximately $17.2 million.
• Analyst upgrades for Tenet Healthcare include a price target increase from Morgan Stanley to $210.00, and the stock currently has an average rating of Moderate Buy with a price target of $195.50.

Dynamic Technology Lab Private Ltd trimmed its holdings in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) by 83.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,410 shares of the company's stock after selling 11,950 shares during the period. Dynamic Technology Lab Private Ltd's holdings in Tenet Healthcare were worth $324,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new stake in shares of Tenet Healthcare in the 1st quarter worth approximately $26,000. Wayfinding Financial LLC bought a new stake in Tenet Healthcare during the first quarter worth approximately $28,000. SVB Wealth LLC bought a new position in Tenet Healthcare during the 1st quarter valued at $30,000. N.E.W. Advisory Services LLC acquired a new position in shares of Tenet Healthcare during the 1st quarter valued at $31,000. Finally, Brooklyn Investment Group raised its stake in shares of Tenet Healthcare by 908.7% in the 1st quarter. Brooklyn Investment Group now owns 232 shares of the company's stock worth $31,000 after buying an additional 209 shares in the last quarter. Institutional investors own 95.44% of the company's stock.

Insider Buying and Selling

In other news, Director Christopher S. Lynch sold 3,952 shares of the business's stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $176.39, for a total transaction of $697,093.28. Following the transaction, the director directly owned 12,358 shares in the company, valued at $2,179,827.62. The trade was a 24.23% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Lisa Y. Foo sold 8,000 shares of the stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $179.53, for a total value of $1,436,240.00. Following the sale, the executive vice president owned 20,878 shares of the company's stock, valued at approximately $3,748,227.34. This represents a 27.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 90,722 shares of company stock worth $17,161,015. 0.81% of the stock is owned by company insiders.

Tenet Healthcare Trading Up 3.8%

NYSE THC traded up $6.93 on Thursday, hitting $190.40. 1,174,669 shares of the stock were exchanged, compared to its average volume of 1,068,109. The company's 50-day moving average price is $174.96 and its two-hundred day moving average price is $156.62. The company has a market capitalization of $16.82 billion, a price-to-earnings ratio of 12.19, a P/E/G ratio of 0.79 and a beta of 1.55. Tenet Healthcare Corporation has a 52-week low of $109.82 and a 52-week high of $199.99. The company has a debt-to-equity ratio of 2.39, a current ratio of 1.71 and a quick ratio of 1.63.

Tenet Healthcare (NYSE:THC - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The company reported $4.02 earnings per share for the quarter, beating analysts' consensus estimates of $2.84 by $1.18. Tenet Healthcare had a return on equity of 24.69% and a net margin of 7.17%.The business had revenue of $5.27 billion for the quarter, compared to the consensus estimate of $5.16 billion. During the same quarter in the previous year, the company posted $2.31 earnings per share. Tenet Healthcare's revenue for the quarter was up 3.2% compared to the same quarter last year. Tenet Healthcare has set its FY 2025 guidance at 15.550-16.210 EPS. Research analysts predict that Tenet Healthcare Corporation will post 12.24 EPS for the current year.

Analysts Set New Price Targets

A number of research analysts recently issued reports on THC shares. Guggenheim lifted their target price on Tenet Healthcare from $180.00 to $188.00 and gave the stock a "buy" rating in a report on Wednesday, July 23rd. Wells Fargo & Company boosted their target price on shares of Tenet Healthcare from $195.00 to $200.00 and gave the stock an "overweight" rating in a report on Thursday, August 14th. UBS Group raised their target price on shares of Tenet Healthcare from $230.00 to $238.00 and gave the stock a "buy" rating in a report on Wednesday, July 23rd. Wall Street Zen raised Tenet Healthcare from a "hold" rating to a "strong-buy" rating in a report on Saturday, July 26th. Finally, Morgan Stanley raised their price objective on Tenet Healthcare from $175.00 to $210.00 and gave the stock an "overweight" rating in a research note on Monday, June 9th. One investment analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, Tenet Healthcare has an average rating of "Moderate Buy" and an average target price of $196.81.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.